FDA Announces 2 Recalls of Potassium Chloride Drugs Across US

Two announcements posted on the U.S. Food and Drug and Administration (FDA) website announced the recall of two potassium prescription medications.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Announcements posted on the U.S. Food and Drug Administration (FDA) website announced the recall of two potassium prescription medications due to the “failed dissolution” of both products.

Glenmark Pharmaceuticals said that the recall impacts 114 batches of 750 mg potassium chloride extended-release capsules, which are prescription-only, because the capsules “may cause high potassium levels,” known as hyperkalemia. The condition can cause an irregular heartbeat that can “lead to cardiac arrest,” the notice warned.